SCHEMBL6026580

SCHEMBL6026580

CSCOc1cc2c(OC3CC(C)CC(C)C3)c(C(=O)OC(C)C)sc2cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6026518 0.91 ACACB (0.31)
SCHEMBL6026694 0.89
SCHEMBL6026471 0.83 COMT (0.36)
SCHEMBL6026496 0.79 PIK3CD (0.36)
SCHEMBL6026426 0.78 STING1 (0.34)
SCHEMBL6026363 0.78 PTGS1 (0.35)
SCHEMBL6026202 0.75 KMT2A (0.38)
SCHEMBL6026232 0.74 STING1 (0.40)
SCHEMBL6025205 0.70 HTR2A (0.39)
SCHEMBL6026420 0.70 COMT (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664037-A1 HALO SUBSTITUTED BENZO [B] THIOPHENES WITH PI3K INHIBITORY ACTIVITY AS THERAPEUTIC AGENTS WARNER-LAMBERT COMPANY LLC (US) 2006-06-07 EP disclosed
US-20050096350-A1 Halo substituted benzo[b]thiophenes as therapeutic agents CONNOLLY MICHAEL K (US) 2005-05-05 US disclosed
WO-2005023800-A1 HALO SUBSTITUTED BENZO`B! THIOPHENES WITH PI3K INHIBITORY ACTIVITY AS THERAPEUTIC AGENTS WARNER-LAMBERT COMPANY LLC (US) 2005-03-17 WO disclosed